China Resources Double-Crane Pharmaceutical Co Ltd Class A 600062
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 21.34
- Day Range
- CNY 21.18–21.87
- 52-Week Range
- CNY 14.80–21.87
- Bid/Ask
- CNY 21.77 / CNY 21.78
- Market Cap
- CNY 22.63 Bil
- Volume/Avg
- 16.5 Mil / 11.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 16.07
- Price/Sales
- 2.16
- Dividend Yield (Trailing)
- 1.33%
- Dividend Yield (Forward)
- 1.33%
- Total Yield
- 1.33%
Company Profile
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 12,269
- Website
- http://www.dcpc.com
Comparables
Valuation
Metric
|
600062
|
600557
|
300016
|
---|---|---|---|
Price/Earnings (Normalized) | 16.07 | 21.90 | — |
Price/Book Value | 1.97 | 2.15 | 1.46 |
Price/Sales | 2.16 | 2.33 | 2.63 |
Price/Cash Flow | 12.29 | 8.72 | 41.36 |
Price/Earnings
600062
600557
300016
Financial Strength
Metric
|
600062
|
600557
|
300016
|
---|---|---|---|
Quick Ratio | 2.08 | 2.19 | 2.84 |
Current Ratio | 2.61 | 2.52 | 3.76 |
Interest Coverage | 114.99 | — | −0.39 |
Quick Ratio
600062
600557
300016
Profitability
Metric
|
600062
|
600557
|
300016
|
---|---|---|---|
Return on Assets (Normalized) | — | 7.20% | −2.34% |
Return on Equity (Normalized) | — | 9.86% | −3.88% |
Return on Invested Capital (Normalized) | — | 9.16% | −1.18% |
Return on Assets
600062
600557
300016
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hzdpjlsbs | Mzcw | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Fgmspwzx | Yczcylj | $70.9 Bil | |
HLN
| Haleon PLC ADR | Gkmrdcsk | Trqj | $37.8 Bil | |
VTRS
| Viatris Inc | Qywtxlhp | Pvrw | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jqgspjlb | Bngn | $12.7 Bil | |
CTLT
| Catalent Inc | Svlxsjm | Nwxry | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Slgkkdkb | Bvvgw | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Nsclpmnr | Dvqy | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ssqkycns | Mnjbpt | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Rxrsjsfn | Cnz | $3.1 Bil |